Screener
Acadia Pharmaceuticals ACAD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $307.96M+16.4% | $268.06M+9.7% | $283.99M+9.4% | $278.63M+11.3% | $264.57M+9.3% | ||
| $28.32M+36.6% | $24.79M+21.6% | $26.23M+20.3% | $21.65M+14.8% | $20.73M+13.7% | ||
| $279.64M+14.7% | $243.27M+8.6% | $257.76M+8.4% | $256.99M+11.0% | $243.83M+9.0% | ||
| 90.8%-1.4pp | 90.8%-0.9pp | 90.8%-0.8pp | 92.2%-0.2pp | 92.2%-0.3pp | ||
| $81.56M+4.6% | $76.87M-1.8% | $84.76M-15.9% | $87.83M+31.9% | $77.95M+2.3% | ||
| $160.25M+20.0% | $171.02M+35.3% | $155.62M+19.6% | $133.4M+0.1% | $133.51M+14.0% | ||
| $270.12M+16.3% | $272.68M+21.2% | $266.6M+151% | $242.88M+11.0% | $232.19M+9.8% | ||
| $37.84M+16.9% | -$4.62M-124% | $17.39M-88.7% | $35.76M+13.0% | $32.37M+6.4% | ||
| 12.3%0.0pp | -1.7%-9.6pp | 6.1%-53.0pp | 12.8%+0.2pp | 12.2%-0.3pp | ||
| $7.99M+10.3% | $8.06M+1.9% | $8.33M+18.9% | $8.25M+25.2% | $7.24M+13.9% | ||
| $647K+8.9% | $542K-7.8% | $596K+3.7% | $593K+3.0% | $594K+53.9% | ||
| $46.47M+15.6% | $3.98M-85.7% | $26.32M-83.7% | $44.6M+14.9% | $40.21M+8.1% | ||
| $14.97M+10.5% | $344K-96.1% | -$247.25M-1,526% | -$27.18M-550% | $13.55M+257% | ||
| $31.5M+18.1% | $3.64M-80.8% | $273.57M+90.3% | $71.78M+119% | $26.67M-20.1% | ||
| 10.2%+0.1pp | 1.4%-6.4pp | 96.3%+41.0pp | 25.8%+12.7pp | 10.1%-3.7pp | ||
| $0.18+12.5% | $0.02-81.8% | $1.61+87.2% | $0.42+110% | $0.16-20.0% | ||
| $40.99M+16.1% | -$1.62M-107% | $20.32M-87.2% | $38.71M+13.1% | $35.31M+7.0% | ||
| 13.3%0.0pp | -0.6%-9.7pp | 7.2%-54.0pp | 13.9%+0.2pp | 13.3%-0.3pp | ||
| $37.84M+16.9% | -$4.62M-124% | $17.39M-88.7% | $35.76M+13.0% | $32.37M+6.4% |
FAQ
- What is Acadia Pharmaceuticals's revenue?
- Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 11.8% year over year.
- Is Acadia Pharmaceuticals profitable?
- Acadia Pharmaceuticals reported $380.5M in net income over the trailing twelve months, a 33.4% net margin.
- What are Acadia Pharmaceuticals's profit margins?
- Gross margin is 91.1% and operating margin is 7.6%, with a 33.4% net margin.
- What is Acadia Pharmaceuticals's earnings per share?
- Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.23.
- Where does Acadia Pharmaceuticals's income statement data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
